CLNNW (CLNNW)

AI-Powered SEC Filing Analysis

Insider Trading Filed: 2026-01-07

Key Insights

  • Chidozie Ugwumba, a director of Clene Inc. (CLNN), has been selling shares in the company over the past three trading days, disposing of a total of 12,918 shares.
  • The shares were sold at prices ranging from $5.87 to $6.29 per share, suggesting Ugwumba may be taking some profits after a recent run-up in the stock price.
  • The insider selling, while not necessarily a negative signal, may warrant further monitoring to see if the trend continues or if Ugwumba's ownership stake changes significantly.
Insider Trading Filed: 2026-01-02

Key Insights

  • Chidozie Ugwumba, a director at Clene Inc., has been selling shares in the company, disposing of a total of 17,110 shares on December 31, 2025 and January 2, 2026 at an average price of $5.77 per share.
  • The sales represent a reduction in Ugwumba's indirect beneficial ownership in Clene Inc. from 770,495 shares to 766,480 shares.
  • Insider selling can sometimes signal a lack of confidence in the company's future prospects, so this transaction may warrant further investigation by investors.
Insider Trading Filed: 2025-12-31

Key Insights

  • Chidozie Ugwumba, a director of Clene Inc. (CLNN), sold 12,234 shares of the company's common stock on December 29-30, 2025 for a total of approximately $73,000.
  • The sale represents a small portion (approximately 1.6%) of Ugwumba's indirect beneficial ownership in Clene, which remains substantial at over 783,000 shares.
  • Insider selling can sometimes signal management's view on the company's near-term prospects, but the relatively small size of this transaction suggests it may not be a significant indicator of Clene's outlook.
Insider Trading Filed: 2025-12-30

Key Insights

  • Chidozie Ugwumba, a director of Clene Inc., exercised pre-funded warrants to acquire 424,358 shares of common stock at $0.001 per share, indicating their confidence in the company's future.
  • Ugwumba also sold 11,671 shares of Clene Inc. common stock on the open market at an average price of around $6.29, which could suggest some profit-taking.
  • The nature of the transactions, a mix of exercising warrants and selling shares, suggests that Ugwumba is actively managing their position in Clene Inc.

Get real-time filing analysis in the app

Download on the App Store

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.